Morten Aleksandr Engel

Director/Board Member at PARATEK PHARMACEUTICALS, INC.

Health Technology

Finance

Commercial Services

Profile

Morten Aleksandr Engel is currently Director at AFYX Therapeutics AS and Paratek Pharmaceuticals, Inc., and Partner at Novo Planetary Health since 2023.
Former positions include Chief Executive Officer at Benchmark Genetics Norway AS, Asset Director at Novo Holdings A, Director at Servier Symphogen.
A and Xellia Pharmaceuticals ApS, Director at Novo Principal Investments from 2016 to 2018, Vice President at Baxter International, Inc., Principal at McKinsey & Co., Inc., Thomson Scientific & Healthcare, and Pfizer (St. Louis), and Partner at Novo Seeds from 2018 to 2024.
Education includes a doctorate conferred in 1999 and a graduate degree conferred in 1995, both from the Massachusetts Institute of Technology.

Morten Aleksandr Engel active positions

Companies	Position	Start
PARATEK PHARMACEUTICALS, INC.	Director/Board Member	-
AFYX Therapeutics AS AFYX Therapeutics AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Director/Board Member	-

All active positions of Morten Aleksandr Engel

Former positions of Morten Aleksandr Engel

Companies	Position	End
Novo Seeds Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement.	Private Equity Investor	2024-12-30
Novo Principal Investments Novo Principal Investments Investment ManagersFinance Novo Principal invests in public and private companies located across Europe and North America. The firm focuses on companies operating in the fields of healthcare and life science sectors. It provides financing for later stage capital requirements.	Private Equity Investor	2018-01-31
BENCHMARK GENETICS NORWAY AS BENCHMARK GENETICS NORWAY AS BiotechnologyHealth Technology Provides breeding and genetics solutions for aquaculture	Chief Executive Officer	-
Xellia Pharmaceuticals ApS Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Provides anti-infective treatments and other critical care therapies services	Director/Board Member	-
Symphogen A/S Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers	Director/Board Member	-

See the detail of Morten Aleksandr Engel's experience

Training of Morten Aleksandr Engel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Morten Aleksandr Engel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Baxter International, Inc. Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services	Health Technology
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
Novo Holdings A/S (Denmark) Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager	Finance
Thomson Scientific & Healthcare Thomson Scientific & Healthcare Internet Software/ServicesTechnology Services Provides integrated information solutions to researchers, librarians, physicians, pharmacists and other professionals	Technology Services
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
Pfizer (St. Louis) Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals	Health Technology
Symphogen A/S Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers	Health Technology
Novo Seeds Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement.	Finance
Xellia Pharmaceuticals ApS Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Provides anti-infective treatments and other critical care therapies services	Health Services
Novo Principal Investments Novo Principal Investments Investment ManagersFinance Novo Principal invests in public and private companies located across Europe and North America. The firm focuses on companies operating in the fields of healthcare and life science sectors. It provides financing for later stage capital requirements.	Finance
Paratek Pharmaceuticals, Inc. Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Health Technology
AFYX Therapeutics AS AFYX Therapeutics AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
BENCHMARK GENETICS NORWAY AS BENCHMARK GENETICS NORWAY AS BiotechnologyHealth Technology Provides breeding and genetics solutions for aquaculture	Health Technology